Navigation Links
SemBioSys announces first quarter 2008 financial and operational results
Date:5/9/2008

- Canadian Biotechnology Company marks key milestones with insulin and Apo

AI programs -

TSX symbol: SBS

CALGARY, May 9 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced its 2008 first quarter operational and financial results.

Highlights

- Prepared pilot scale quantities of insulin from its facilities and

initiated the final animal toxicology study for safflower-produced

insulin

- Initiated animal studies of the Company's safflower-produced Apo

AI(Milano) that will provide important cholesterol mobilization data,

subsequent to the end of the quarter

- Announced Burt's Bees launched three products containing Hydresia(TM)

in the U.S. personal care market, representing Botaneco's (a wholly-

owned subsidiary of SemBioSys) first national brand name customer

- Received a $350,000 milestone payment from AVAC Ltd. in recognition

of critical advances in the Company's safflower-produced insulin

program and a $500,000 milestone payment from AVAC to support the

commercial activities of Botaneco

- Launched the second generation oleosome product, Hydresia(TM) G2,

subsequent to the end of the quarter

Outlook

SemBioSys is currently conducting all the necessary preclinical work for safflower-produced insulin to enable it to file an IND application with the FDA in the second half of 2008 which would then, pending feedback from the FDA, allow it to proceed into human clinical trials in the second half of 2008. The upcoming insulin milestone events include:

- Submission of an IND to the FDA in the second half of 2008 upon

completion of the toxicology studies of safflower-produced in
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. SemBioSys receives milestone payments from AVAC Ltd.
2. SemBioSys initiates toxicology study for safflower-produced insulin
3. SemBioSys announces 2007 financial and operational results
4. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
5. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
6. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
7. SemBioSys signs option agreement for safflower-produced food ingredient
8. SemBioSys announces 2007 third quarter results
9. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
10. SemBioSys updates Apo AI development program
11. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... July 18, 2014 Emerging Nuclear Power ... to 2030 , Summary , The latest report from ... Companies and Development Analysis to 2030 covers the emerging ... also provides comprehensive information on key market players and ... reactors in various countries across the world has also ...
(Date:7/18/2014)... BASEL, Switzerland , July 18, 2014 ... for Education in Animal Research for the third consecutive ... Moscow State University, will attend a 1-week course at ... rules of the 3Rs (Replace, Reduce, Refine). As head ... University, Popov has been given the task of adapting ...
(Date:7/17/2014)... MOUNTAIN VIEW, Calif. , July 17, ... in translational preclinical research, today announced the addition of ... expert veterinary interventionalist, and Benigno Mills , a ... Team. In addition, to better serve our clients, we ... media accounts on Twitter , Facebook ...
(Date:7/17/2014)... devices can only work with a certain incident polarization ... shift the polarization direction of linearly polarized light. A ... out of a birefringent material (such as quartz or ... the thickness of the crystal, the wavelength of light. ... difficulty to integrate on circuits. Then what kind of ...
Breaking Biology Technology:Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 3
... Switzerland, May 16 Arpida Ltd.,(SWX: ARPN) today announced ... for review the New Drug Application (NDA) for,intravenous iclaprim ... (cSSSI). Arpida completed the submission of the NDA to,the ... ten month review to,the iclaprim NDA and has established ...
... Million - ... - Gross Profit Up; Net Loss Down -, TUSTIN, ... a vertically integrated specialty pharmaceutical company headquartered,in Tustin, California, with ... subsidiary Jade Pharmaceutical Inc. (JPI),the Company engages in the research, ...
... Principle Reached to Terminate Marketing Agreement with Triax ... on Most Favorable Terms, NAPA, Calif., May 15 ... company engaged in the development,of technologies that target the ... quarter ended March 31, 2008 and an agreement in,principle ...
Cached Biology Technology:Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million 2AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million 3Senetek PLC Reports First Quarter 2008 Financial Results 2Senetek PLC Reports First Quarter 2008 Financial Results 3
(Date:7/21/2014)... high-fat foods cause you to lose your sense of ... neuroscientists says so, and it has researchers taking a ... whole range of human functions that were not traditionally ... opens up a lot of possibilities for obesity research," ... led the study examining how high-fat foods impacted smell. ...
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
(Date:7/21/2014)... animals cannot regulate their body temperature, so their cells ... at slightly colder temperatures, some biological processes in the ... throw the cells, delicate chemical balance out of whack. ... coordinated. Now researchers from the University of Rochester and ... they do that. , "The production of proteins ...
Breaking Biology News(10 mins):New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2
... must address ecological threats, a top international scientific meeting ... the planet,s natural limits in a striking parallel to ... a subprime loan," Dr. Johan Rockstrm of the Stockholm ... risks of both kinds of crises in the future. ...
... a multi-year $1 million sponsored research agreement with ... the maker of Smart Balance buttery spread and ... cholesterol through a patented blend of natural vegetable ... entered into a collaboration and license to develop ...
... 6, 2008, Cambridge, UK ,Discussion of a man,s background, ... and The City episodes in the future, it could ... Risk of developing type 2 diabetes and metabolic ... this background has in turn been influenced by environment and ...
Cached Biology News:Top scientific meeting urges coordinated response to economic and environmental crises 2Brandeis and Smart Balance team up to advance heart-healthy research 2Coping and copulation behavior may help calculate diabetes risk 2